Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Genipin and EDC crosslinking of extracellular matrix hydrogel derived from human umbilical cord for neural tissue repair

K. Výborný, J. Vallová, Z. Kočí, K. Kekulová, K. Jiráková, P. Jendelová, J. Hodan, Š. Kubinová,

. 2019 ; 9 (1) : 10674. [pub] 20190723

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Extracellular matrix (ECM) hydrogels, produced by tissue decellularization are natural injectable materials suitable for neural tissue repair. However, the rapid biodegradation of these materials may disrupt neural tissue reconstruction in vivo. The aim of this study was to improve the stability of the previously described ECM hydrogel derived from human umbilical cord using genipin and N-(3-Dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC), crosslinking at concentration of 0.5-10 mM. The hydrogels, crosslinked by genipin (ECM/G) or EDC (ECM/D), were evaluated in vitro in terms of their mechanical properties, degradation stability and biocompatibility. ECM/G, unlike ECM/D, crosslinked hydrogels revealed improved rheological properties when compared to uncrosslinked ECM. Both ECM/G and ECM/D slowed down the gelation time and increased the resistance against in vitro enzymatic degradation, while genipin crosslinking was more effective than EDC. Crosslinkers concentration of 1 mM enhanced the in vitro bio-stability of both ECM/G and ECM/D without affecting mesenchymal stem cell proliferation, axonal sprouting or neural stem cell growth and differentiation. Moreover, when injected into cortical photochemical lesion, genipin allowed in situ gelation and improved the retention of ECM for up to 2 weeks without any adverse tissue response or enhanced inflammatory reaction. In summary, we demonstrated that genipin, rather than EDC, improved the bio-stability of injectable ECM hydrogel in biocompatible concentration, and that ECM/G has potential as a scaffold for neural tissue application.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028870
003      
CZ-PrNML
005      
20210114155240.0
007      
ta
008      
210105s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-019-47059-x $2 doi
035    __
$a (PubMed)31337821
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Výborný, Karel $u Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic. 2nd Medical Faculty, Charles University, Prague, Czech Republic.
245    10
$a Genipin and EDC crosslinking of extracellular matrix hydrogel derived from human umbilical cord for neural tissue repair / $c K. Výborný, J. Vallová, Z. Kočí, K. Kekulová, K. Jiráková, P. Jendelová, J. Hodan, Š. Kubinová,
520    9_
$a Extracellular matrix (ECM) hydrogels, produced by tissue decellularization are natural injectable materials suitable for neural tissue repair. However, the rapid biodegradation of these materials may disrupt neural tissue reconstruction in vivo. The aim of this study was to improve the stability of the previously described ECM hydrogel derived from human umbilical cord using genipin and N-(3-Dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC), crosslinking at concentration of 0.5-10 mM. The hydrogels, crosslinked by genipin (ECM/G) or EDC (ECM/D), were evaluated in vitro in terms of their mechanical properties, degradation stability and biocompatibility. ECM/G, unlike ECM/D, crosslinked hydrogels revealed improved rheological properties when compared to uncrosslinked ECM. Both ECM/G and ECM/D slowed down the gelation time and increased the resistance against in vitro enzymatic degradation, while genipin crosslinking was more effective than EDC. Crosslinkers concentration of 1 mM enhanced the in vitro bio-stability of both ECM/G and ECM/D without affecting mesenchymal stem cell proliferation, axonal sprouting or neural stem cell growth and differentiation. Moreover, when injected into cortical photochemical lesion, genipin allowed in situ gelation and improved the retention of ECM for up to 2 weeks without any adverse tissue response or enhanced inflammatory reaction. In summary, we demonstrated that genipin, rather than EDC, improved the bio-stability of injectable ECM hydrogel in biocompatible concentration, and that ECM/G has potential as a scaffold for neural tissue application.
650    _2
$a karbodiimidy $x aplikace a dávkování $7 D002234
650    _2
$a proliferace buněk $x fyziologie $7 D049109
650    _2
$a extracelulární matrix $x chemie $7 D005109
650    _2
$a lidé $7 D006801
650    _2
$a hydrogely $x chemie $7 D020100
650    12
$a iridoidy $7 D039823
650    _2
$a mezenchymální kmenové buňky $x cytologie $7 D059630
650    _2
$a regenerace nervu $x fyziologie $7 D009416
650    _2
$a tkáňové inženýrství $7 D023822
650    _2
$a tkáňové podpůrné struktury $x chemie $7 D054457
650    _2
$a pupečník $x cytologie $7 D014470
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vallová, Jana $u Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic. 2nd Medical Faculty, Charles University, Prague, Czech Republic.
700    1_
$a Kočí, Zuzana $u Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Kekulová, Kristýna $u Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic. 2nd Medical Faculty, Charles University, Prague, Czech Republic.
700    1_
$a Jiráková, Klára $u Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Jendelová, Pavla $u Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Hodan, Jiří $u Institute of Macromolecular Chemistry of the Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Kubinová, Šárka $u Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic. sarka.kubinova@iem.cas.cz.
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 9, č. 1 (2019), s. 10674
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31337821 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114155238 $b ABA008
999    __
$a ok $b bmc $g 1609205 $s 1120050
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 9 $c 1 $d 10674 $e 20190723 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20210105

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...